Ribostamycin
From Wikipedia, the free encyclopedia
Ribostamycin
 |
| Systematic (IUPAC) name |
| (1R,2R,3S,4R,6S)-4,6-diamino-3-hydroxy-2-(β-D-ribofuranosyloxy)cyclohexyl 2,6-diamino-2,6-dideoxy-α-D-glucopyranoside |
| Clinical data |
| AHFS/Drugs.com |
International Drug Names |
| Pregnancy cat. |
? |
| Legal status |
? |
| Identifiers |
| CAS number |
 Y 53797-35-6 |
| ATC code |
J01GB10 |
| PubChem |
CID 5066 |
| UNII |
2Q5JOU7T53  N |
| ChEMBL |
CHEMBL1256830 N |
| Synonyms |
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2-{[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxycyclohexyl]oxy}oxane-3,4-diol |
| Chemical data |
| Formula |
C17H34N4O10 |
| Mol. mass |
454.47266 g/mol |
 N (what is this?) (verify)
|
Ribostamycin (INN) is an aminoglycoside antibiotic.
53797-35-6
(what is this?) (verify)
